Adverse Reaction Clinical Trials in Seoul
2 recruitingSeoul, South Korea
Showing 1–2 of 2 trials
Recruiting
Phase 4
Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI
Myocardial InfarctionStatin Adverse ReactionHMG-CoA Reductase Inhibitor Toxicity
Kiyuk Chang, MD,PhD3,548 enrolled7 locationsNCT04499859
Recruiting
Phase 4
Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation
Atrial FibrillationAnticoagulant Adverse Reaction
Korea University Anam Hospital940 enrolled1 locationNCT06187311